NEW YORK] Shein Group lowered US retail prices this week after the Trump administration temporarily cut duties on Chinese ...

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

Hong Kong is calling for robotaxi operator Pony AI . The $6 billion Chinese company is exploring an offering in the city just ...

By Scott Murdoch (Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is aiming to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong listing, according to a ...

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

And another scoop: Two of FTI Consulting’s top economics experts in Europe have left to join Jonathan Orszag’s upstart rival ...

Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong listing, according to a regulatory filing made on Thursday.

Pony.ai, which raised USD 413 million in a US IPO, is now planning a Hong Kong listing to fuel further expansion. The company operates 250 robotaxis and is developing mass production models with ...

Jiangsu Hengrui Pharmaceuticals Co. has started taking investor orders for a Hong Kong listing that could raise as much as ...

Indian stock markets are likely to open on a positive note amid mixed global cues, and a lack of major domestic triggers ...

Shares of Etoro jumped 29% in their trading debut on Wednesday after the brokerage platform raised almost $310 million in an initial public offering. The stock’s closing price of $67 gave the company ...